Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.

Kim WY, Jeon YK, Kim TM, Kim JE, Kim YA, Lee SH, Kim DW, Heo DS, Kim CW.

Ann Oncol. 2009 Oct;20(10):1688-96. doi: 10.1093/annonc/mdp056. Epub 2009 Jun 19.

PMID:
19542249
2.

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project.

Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO, Liang R; International Peripheral T-Cell Lymphoma Project..

Blood. 2009 Apr 23;113(17):3931-7. doi: 10.1182/blood-2008-10-185256. Epub 2008 Nov 24.

3.

Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group.

Kim TM, Lee SY, Jeon YK, Ryoo BY, Cho GJ, Hong YS, Kim HJ, Kim SY, Kim CS, Kim S, Kim JS, Sohn SK, Song HH, Lee JL, Kang YK, Yim CY, Lee WS, Yuh YJ, Kim CW, Heo DS; Lymphoma Subcommittee of the Korean Cancer Study Group..

Ann Oncol. 2008 Aug;19(8):1477-84. doi: 10.1093/annonc/mdn147. Epub 2008 Apr 2.

PMID:
18385201
4.

Extranodal NK/T-cell lymphoma: diagnosis and treatment cues.

Suzuki R, Takeuchi K, Ohshima K, Nakamura S.

Hematol Oncol. 2008 Jun;26(2):66-72. doi: 10.1002/hon.847. Review.

PMID:
18283711
5.

Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru.

Barrionuevo C, Zaharia M, Martinez MT, Taxa L, Misad O, Moscol A, Sarria G, Guerrero I, Casanova L, Flores C, Zevallos-Giampietri EA.

Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):38-44.

PMID:
17536305
6.

Extranodal NK/T-cell lymphoma, nasal type.

Al-Hakeem DA, Fedele S, Carlos R, Porter S.

Oral Oncol. 2007 Jan;43(1):4-14. Epub 2006 Oct 24. Review.

PMID:
17064952
7.

CT of nasal-type T/NK cell lymphoma in the lung.

Lee BH, Kim SY, Kim MY, Hwang YJ, Han YH, Seo JW, Kim YH, Cha SJ, Hur G.

J Thorac Imaging. 2006 Mar;21(1):37-9.

PMID:
16538154
8.

NK/T cell lymphoma of the lung: a case report and review of literature.

Laohaburanakit P, Hardin KA.

Thorax. 2006 Mar;61(3):267-70. Review.

9.

NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.

Pagano L, Gallamini A, Trapè G, Fianchi L, Mattei D, Todeschini G, Spadea A, Cinieri S, Iannitto E, Martelli M, Nosari A, Bona ED, Tosti ME, Petti MC, Falcucci P, Montanaro M, Pulsoni A, Larocca LM, Leone G; Intergruppo Italiano Linfomi..

Ann Oncol. 2006 May;17(5):794-800. Epub 2006 Feb 23.

PMID:
16497823
10.

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.

Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon HC, Kim HJ, Lee SI, Kim JH, Park J, Oh SJ, Kim K, Jung C, Park K, Kim WS.

J Clin Oncol. 2006 Feb 1;24(4):612-8. Epub 2005 Dec 27.

PMID:
16380410
11.

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.

Kim TM, Park YH, Lee SY, Kim JH, Kim DW, Im SA, Kim TY, Kim CW, Heo DS, Bang YJ, Chang KH, Kim NK.

Blood. 2005 Dec 1;106(12):3785-90. Epub 2005 Aug 18.

12.

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.

Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, Park KW, Kang JH, Park JO, Lee SH, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Ko YH, Ahn YC, Park K.

Eur J Cancer. 2005 Jul;41(10):1402-8.

PMID:
15963893
13.

The pathology of NK-cell lymphomas and leukemias.

Nava VE, Jaffe ES.

Adv Anat Pathol. 2005 Jan;12(1):27-34. Review.

PMID:
15614162
14.

Nasal-type NK/T cell lymphoma of the orbit with distant metastases.

Kuwabara H, Tsuji M, Yoshii Y, Kakuno Y, Akioka T, Kotani T, Iwao N, Hanafusa T, Ikeda T, Mori H.

Hum Pathol. 2003 Mar;34(3):290-2.

PMID:
12673566
15.

Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.

Avilés A, Neri N, Fernández R, Calva A, Huerta-Guzmán J, Nambo MJ.

Med Oncol. 2003;20(1):13-7.

PMID:
12665679
16.

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality.

Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):182-90.

PMID:
12182990
17.

Cutaneous dissemination of nasal NK/T-cell lymphoma with bone marrow, liver and lung involvement.

Chang SE, Lee SY, Choi JH, Sung KJ, Moon KC, Koh JK.

Clin Exp Dermatol. 2002 Mar;27(2):120-2.

PMID:
11952703

Supplemental Content

Support Center